Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN106892860B offers cost-effective Alectinib intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Novel asymmetric catalysis method improves yield and purity for Carfilzomib intermediate manufacturing ensuring supply chain stability and cost efficiency.
Patent CN103570699A reveals a high-yield synthesis for prucalopride intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN113045579B details a novel total synthesis of Anthrabenzoxocinones antibiotics. This route offers scalable production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114262290B reveals silver-catalyzed synthesis for high-purity heterocyclic compounds. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN107001294B reveals a novel mild process for ultra-high purity gadobutrol. Discover cost-effective manufacturing strategies and reliable supply chain solutions.
Patent CN114539251A reveals a green, one-step silver-catalyzed route for pyrido[2,3-d]pyrimidine derivatives, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN117567441A reveals novel anti-inflammatory synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN117586274B reveals novel forskolin ring-expansion synthesis. Offers high-purity intermediates with streamlined scalability for global pharmaceutical supply chains.
Patent CN101007793A reveals optimized EHATA synthesis reducing waste. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Discover efficient chromone-based routes for high-purity pyrimidine derivatives. Enhance your antiviral pipeline with scalable, cost-effective pharmaceutical intermediates.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane, offering significant supply chain advantages for Drospirenone manufacturers.
Patent CN101343306B reveals a low-cost synthesis for 6,7-methylene steroids using dibromomethane. Ideal for Drospirenone intermediates with reduced production costs.
Novel patent CN103664960B details metal-free Ponatinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107033124B details a streamlined Alectinib route reducing purification steps. This offers supply chain stability and cost efficiency for global pharmaceutical manufacturing partners.
Novel spiro-containing dihydropyrimidine derivatives with antitumor activity. Efficient synthesis route offers cost reduction and scalability for pharmaceutical intermediates.
Novel patent CN108658931A offers high-yield route for Raltitrexed intermediate. Reduces toxic waste and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN101786983A reveals a mild one-pot synthesis for 2-amino-1,2-dihydroisoquinolines using AgOTF and NHC catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN117362311A reveals novel forskolin analogue synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.